Breast Health Program

HOSPITAL
University Hospitals Seidman Cancer Center

KEY CONTACTS
Jill Dietz, MD, Physician Co-Lead, Breast Surgery, Jill.Dietz@UHhospitals.org
Paula Silverman, MD, Disease Team Leader, Medical Oncology, Paula.Silverman@UHhospitals.org

Leila Woehrle, RN, New Patient Access Coordinator 216-844-8988, Leila.Woehrle1@UHhospitals.org
Donna Plecha, MD, Director, Breast Imaging 216-844-5330, Donna.Plecha@UHhospitals.org
Janice Lyons, Director, Breast Radiation Oncology 216-896-6570, Janice.Lyons@UHhospitals.org
Hannah Gilmore, Director, Breast Pathology 216-286-6587, Hannah.Gilmore@UHhospitals.org

APPOINTMENT LINE
For hospital transfers, please call 216-844-1111.

BREAST CANCER AND BREAST CANCER PREVENTION SERVICES

• Center for Breast Cancer Prevention
o Breast evaluation and risk assessment
o Genetic evaluation
o Design of individualized prevention care plan
o MRI for high risk

• Diagnostic imaging and image-guided biopsies
o Digital and 3-D mammography
o Screening, diagnostic and implant rupture breast MRI
o Diagnostic and screening ultrasound
o Evaluation for patients with increased breast density
o Stereotactic, MRI and ultrasound-guided biopsies
o Walk-in screening mammogram
o Same-day diagnostic mammogram and image-guided biopsy availability

• Surgery
o Diagnostic breast biopsies
o Directed duct excision and ductoscopy for pathologic nipple discharge
o Risk-reducing surgery, including nipple-sparing mastectomy
o Oncoplastic breast surgery
o Definitive breast cancer surgery

• Plastic surgery
o Tissue reconstruction
o Implant reconstruction
o Cosmetic surgery
o Therapeutic lymphedema surgery

• Radiation therapy
o Breast-conserving management
o Partial breast radiation
o Cardiac-sparing techniques
o Only Proton Therapy Center in Ohio
o Palliative radiation

• Medical oncology
o Adjuvant and neoadjuvant chemotherapy and hormonal treatment
o Systemic treatment for metastatic disease
  • Chemotherapy and immunotherapy
  • Hormonal treatment
  • Targeted treatment

• Survivorship program
o End of treatment summary
o Follow-up plan
o Risk reduction
o Health education and awareness
o Wellness
o Long-term follow-up and surveillance for recurrence

• Supportive cancer care
o Nutritional evaluation and support
o Integrative medicine additions and alternatives
o OT/PT and lymphedema care and preventive strategies
o Wellness education and classes
o Finance, social work and psychology support services
o Cardio-oncology

• Pathology
o Expert pathology review
o Immunohistochemistry for breast cancer markers (e.g., androgen receptor)
o Interdisciplinary team integration
o Genomic assays

• Multidisciplinary treatment planning
o Multidisciplinary breast cancer tumor board weekly
o Multidisciplinary genomic tumor board
o Center for Breast Cancer Prevention Case Management Conference
o Radiology/Pathology Consensus Conference for benign breast lesions
o National leadership in clinical pathway development (ASBrS, NAPBC, NCCN, NRG, ARRS)

• Clinical trials
o Extensive portfolio of clinical trials of new treatments
o Personalized medicine with targeted agents determined by genomic testin
o Vaccine and immunotherapy trials
o Proton therapy